Press launch MHRA approves GLP –one receptor agonist semaglutide to scale back danger of serious heart issues in obese or overweight Older people Semaglutide is the main weight loss drug approved in britain for a preventative treatment method for anyone with established cardiovascular diseaseTry to eat effectively, live greater, continue to be ba